Value of combined detection of anti‑nuclear antibody, anti‑double‑stranded DNA antibody and C3, C4 complements in the clinical diagnosis of systemic lupus erythematosus

Qu,Changhua; Zhang,Juan; Zhang,Xiumei; Du,Jiexin; Su,Baifang; Li,Hong

doi:10.3892/etm.2018.7072

Value of combined detection of anti‑nuclear antibody, anti‑double‑stranded DNA antibody and C3, C4 complements in the clinical diagnosis of systemic lupus erythematosus

Authors:
- Changhua Qu
- Juan Zhang
- Xiumei Zhang
- Jiexin Du
- Baifang Su
- Hong Li
View Affiliations

Affiliations: Department of Clinical Laboratory, Yantaishan Hospital of Yantai, Yantai, Shandong 264000, P.R. China, Outpatient Department, Yantai Yeda Hospital, Yantai, Shandong 264000, P.R. China, Department of Internal Medicine, The People's Hospital of Zhangqiu Area, Zhangqiu, Shandong 250200, P.R. China, Department of Neurology, The People's Hospital of Zhangqiu Area, Zhangqiu, Shandong 250200, P.R. China, Department of Science and Education, Jinan Zhangqiu District Hospital of TCM, Zhangqiu, Shandong 250200, P.R. China, Department of Clinical Laboratory, The Fifth People's Hospital of Jinan, Jinan, Shandong 250022, P.R. China
Published online on: December 7, 2018 https://doi.org/10.3892/etm.2018.7072
Pages: 1390-1394
Copyright: © Qu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Combined detection of antinuclear antibody (ANA), anti‑double‑stranded DNA (ds‑DNA) antibody and complements C3 and C4 in the diagnosis of systemic lupus erythematosus (SLE) was analyzed. One hundred and ninety‑four patients with SLE admitted to Yantaishan Hospital of Yantai from January 2012 to December 2017 were selected as SLE group. A total of 106 patients with non‑SLE rheumatic disease were selected as disease control group and 120 healthy subjects as healthy control group. The ANA and anti‑ds‑DNA antibodies were detected by ELISA and complement C3 and C4 were detected by rate nephelometry. The sensitivity and specificity of these four factors were also analyzed for the diagnosis of SLE. The sensitivity and specificity of ANA in diagnosing SLE were 91.75 and 79.65%, respectively; of anti‑ds‑DNA antibody were 67.01 and 98.23%, respectively; of complement C3 were 87.11 and 82.74%, respectively; and of complement C4 were 88.66 and 77.43%, respectively. The sensitivity and specificity of ANA and anti‑ds‑DNA antibody in the diagnosis of SLE were 95.36 and 96.90%, respectively; of C3 and C4 were 92.78 and 79.20%, respectively; and the sensitivity and specificity of the combination of all four indicators were 97.42 and 80.97%, respectively. The combined diagnosis of SLE with ANA, anti‑ds‑DNA antibody, complement C3 and C4 can play a complementary role in the diagnosis and treatment of SLE patients, and it is of great significance to the diagnosis and treatment planning of SLE patients.

View Figures

View References

1	Rönnblom L and Pascual V: The innate immune system in SLE: Type I interferons and dendritic cells. Lupus. 17:394–399. 2008. View Article : Google Scholar : PubMed/NCBI
2	Coluccia AM, Cirulli T, Neri P, Mangieri D, Colanardi MC, Gnoni A, Di Renzo N, Dammacco F, Tassone P, Ribatti D, et al: Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: Preclinical efficacy of the novel, orally available inhibitor dasatinib. Blood. 112:1346–1356. 2008. View Article : Google Scholar : PubMed/NCBI
3	Egner W: The use of laboratory tests in the diagnosis of SLE. J Clin Pathol. 53:424–432. 2000. View Article : Google Scholar : PubMed/NCBI
4	Su DL, Wang HJ, Ji XH, Li YY, Xuan HB, Heng C and Li YF: Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Acta Pharmacol Sin. 27:1051–1057. 2006. View Article : Google Scholar : PubMed/NCBI
5	Mackay M, Stanevsky A, Wang T, Aranow C, Li M, Koenig S, Ravetch JV and Diamond B: Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. J Exp Med. 203:2157–2164. 2006. View Article : Google Scholar : PubMed/NCBI
6	Zhao P, Xu L, Wang P, Liang X, Qi J, Liu P, Guo C, Zhang L, Ma C and Gao L: Increased expression of human T-cell immunoglobulin- and mucin-domain-containing molecule-4 in peripheral blood mononuclear cells from patients with system lupus erythematosus. Cell Mol Immunol. 7:152–156. 2010. View Article : Google Scholar : PubMed/NCBI
7	Yu SL, Wong CK, Wong PTY, Chen DP, Szeto CC, Li EK and Tam LS: Down-regulated NOD2 by immunosuppressants in peripheral blood cells in patients with SLE reduces the muramyl dipeptide-induced IL-10 production. PLoS One. 6:e238552011. View Article : Google Scholar : PubMed/NCBI
8	Muratori P, Muratori L, Ferrari R, Cassani F, Bianchi G, Lenzi M, Rodrigo L, Linares A, Fuentes D and Bianchi FB: Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol. 98:431–437. 2003. View Article : Google Scholar : PubMed/NCBI
9	Xu XF, Zhang J, Cui L, Wang YH, Yue Y, Chi L, Bai J, Li HM and Lu XX: The value of different antibodies detection in diagnosis of rheumatism with uveitis. Zhonghua Yi Xue Za Zhi. 97:285–290. 2017.(In Chinese). PubMed/NCBI
10	Song XY, Huang H, Liu YZ, Zhao YY, Li S and Xu ZJ: Coexistence of sarcoidosis and primary Sjögren syndrome: A clinical analysis and literature review. Zhonghua Nei Ke Za Zhi. 56:375–377. 2017.(In Chinese). PubMed/NCBI
11	Buhl A, Metzger JH, Heegaard NH, von Landenberg P, Fleck M and Luppa PB: Novel biosensor-based analytic device for the detection of anti-double-stranded DNA antibodies. Clin Chem. 53:334–341. 2007. View Article : Google Scholar : PubMed/NCBI
12	Calano SJ, Shih PA, Liu CC, Kao AH, Navratil JS, Manzi S and Ahearn JM: Cell-bound complement activation products (CB-CAPs) as a source of lupus biomarkers. Adv Exp Med Biol. 586:381–390. 2006. View Article : Google Scholar : PubMed/NCBI
13	Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40:17251997. View Article : Google Scholar : PubMed/NCBI
14	Liu Y, Jing H, Wang J, Zhang R, Zhang Y, Zhang Y, Xu Q, Yu X and Xue C: Micronutrients decrease incidence of common infections in type 2 diabetic outpatients. Asia Pac J Clin Nutr. 20:375–382. 2011.PubMed/NCBI
15	Salaman MR and Isenberg DA: The immunological personality of close relatives of SLE patients. Lupus. 26:1513–1516. 2017. View Article : Google Scholar : PubMed/NCBI
16	Liu CC, Manzi S, Kao AH, Navratil JS and Ahearn JM: Cell-bound complement biomarkers for SLE: From benchtop to bedside. Rheum Dis Clin North Am. 36:161–172. 2010. View Article : Google Scholar : PubMed/NCBI
17	Kumar Y and Bhatia A: Detection of antinuclear antibodies in SLE. Methods Mol Biol. 1134:37–45. 2014. View Article : Google Scholar : PubMed/NCBI
18	Kasitanon N, Magder LS and Petri M: Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore). 85:147–156. 2006. View Article : Google Scholar : PubMed/NCBI
19	Li LH, Pan HF, Li WX, Li XP, Xu JH and Ye DQ: Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population. Clin Rheumatol. 28:1301–1307. 2009. View Article : Google Scholar : PubMed/NCBI
20	Roggenbuck D, Reinhold D, Hiemann R, Anderer U and Conrad K: Standardized detection of anti-ds DNA antibodies by indirect immunofluorescence - a new age for confirmatory tests in SLE diagnostics. Clin Chim Acta. 412:2011–2012. 2011. View Article : Google Scholar : PubMed/NCBI
21	Waris G and Alam K: Immunogenicity of superoxide radical modified-DNA: Studies on induced antibodies and SLE anti-DNA autoantibodies. Life Sci. 75:2633–2642. 2004. View Article : Google Scholar : PubMed/NCBI
22	Liu H, Yang LH, Yin G and Xie QB: Correlation of thyroid autoantibodies, system lupus erythematosus immunologic indicators and disease activity in SLE with HT. Sichuan Da Xue Xue Bao Yi Xue Ban. 49:179–182. 2018.(In Chinese). PubMed/NCBI